BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND MTCP1, C6_1B, 4515, ENSG00000214827, GS1-273L24_4
23368 results:

  • 1. Development and validation of a nomogram for predicting the occurrence of renal dysfunction after treatment of immune checkpoint inhibitor: a retrospective case-control study.
    Su J; Chen P; Yang Y; Gao Z; Bi Z; Feng M
    BMJ Open; 2024 May; 14(5):e082484. PubMed ID: 38760047
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Evaluating the effects of various ethanolic medicinal plant extracts on metastatic breast cancer proliferation, invasion, and expression of a novel potential drug target; CD82 metastatic suppressor protein, and on in vivo angiogenesis using the ex ovo yolk sac membrane (YSM) assay.
    Loggenberg S; Twilley D; Lall N
    J Cancer Res Clin Oncol; 2024 May; 150(5):257. PubMed ID: 38753184
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways.
    Kurmasheva N; Said A; Wong B; Kinderman P; Han X; Rahimic AHF; Kress A; Carter-Timofte ME; Holm E; van der Horst D; Kollmann CF; Liu Z; Wang C; Hoang HD; Kovalenko E; Chrysopoulou M; Twayana KS; Ottosen RN; Svenningsen EB; Begnini F; Kiib AE; Kromm FEH; Weiss HJ; Di Carlo D; Muscolini M; Higgins M; van der Heijden M; Bardoul A; Tong T; Ozsvar A; Hou WH; Schack VR; Holm CK; Zheng Y; Ruzek M; Kalucka J; de la Vega L; Elgaher WAM; Korshoej AR; Lin R; Hiscott J; Poulsen TB; O'Neill LA; Roy DG; Rinschen MM; van Montfoort N; Diallo JS; Farin HF; Alain T; Olagnier D
    Nat Commun; 2024 May; 15(1):4096. PubMed ID: 38750019
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. End-stage renal disease after renal cancer surgery: risk factors and overall survival.
    Åkerlund J; Ljungberg B; Lundstam S; Peeker R; Holmberg E; Månsson M; Grenabo Bergdahl A
    Scand J Urol; 2024 May; 59():109-116. PubMed ID: 38747153
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Deep Learning Assessment of Small Renal Masses at Contrast-enhanced Multiphase CT.
    Dai C; Xiong Y; Zhu P; Yao L; Lin J; Yao J; Zhang X; Huang R; Wang R; Hou J; Wang K; Shi Z; Chen F; Guo J; Zeng M; Zhou J; Wang S
    Radiology; 2024 May; 311(2):e232178. PubMed ID: 38742970
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Minimally invasive transperitoneal partial versus radical nephrectomy in obese patients: perioperative and long-term functional outcomes from a large perspective contemporary series (RECORd2 project).
    Lambertini L; Mari A; Sandulli A; Amparore D; Antonelli A; Barale M; Bove P; Brunocilla E; Capitanio U; DA Pozzo LF; DI Maida F; Grosso AA; Fiori C; Gontero P; Li Marzi V; Campi R; Longo N; Marchioni M; Montanari E; Montorsi F; Porpiglia F; Porreca A; Schiavina R; Simeone C; Siracusano S; Terrone C; Ficarra V; Minervini A
    Minerva Urol Nephrol; 2024 Apr; 76(2):185-194. PubMed ID: 38742553
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Single-layer versus double-layer renorrhaphy technique during robot-assisted partial nephrectomy: impact on perioperative outcomes, complications, and functional outcomes.
    Bertolo R; Ditonno F; Veccia A; DE Marco V; Migliorini F; Porcaro AB; Rizzetto R; Cerruto MA; Autorino R; Antonelli A
    Minerva Urol Nephrol; 2024 Apr; 76(2):176-184. PubMed ID: 38742552
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma- results from a nation-wide study covering 50 years in Iceland.
    Runarsson TG; Bergmann A; Erlingsdottir G; Petursdottir V; Heitmann LA; Johannesson A; Asbjornsson V; Axelsson T; Hilmarsson R; Gudbjartsson T
    BMC Urol; 2024 May; 24(1):105. PubMed ID: 38741053
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tumor microenvironment and clinical efficacy of first line immunotherapy-based combinations in metastatic renal cell carcinoma.
    Sammarco E; Rossetti M; Salfi A; Bonato A; Viacava P; Masi G; Galli L; Faviana P
    Med Oncol; 2024 May; 41(6):150. PubMed ID: 38740647
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Surface ligand-regulated renal clearance of MRI/SPECT dual-modality nanoprobes for tumor imaging.
    Chen C; Huang B; Zhang R; Sun C; Chen L; Ge J; Zhou D; Li Y; Wu S; Qian Z; Zeng J; Gao M
    J Nanobiotechnology; 2024 May; 22(1):245. PubMed ID: 38735921
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comparison of Perioperative, Functional, and Oncologic Outcomes of Open vs. Robot-Assisted Off-Clamp Partial Nephrectomy: A Propensity Scored Match Analysis.
    Mastroianni R; Chiacchio G; Perpepaj L; Tuderti G; Brassetti A; Anceschi U; Ferriero M; Misuraca L; D'Annunzio S; Bove AM; Guaglianone S; Flammia RS; Proietti F; Pula M; Milanese G; Leonardo C; Galosi AB; Simone G
    Sensors (Basel); 2024 Apr; 24(9):. PubMed ID: 38732928
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comparison of dmft and behavior rating scores between children with systemic disease and healthy children at the first dental visit.
    Erbas Unverdi G; Ozgur B; Gungor HC; Casamassimo PS
    BMC Oral Health; 2024 May; 24(1):548. PubMed ID: 38730438
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Therapeutic Drug Monitoring of Pazopanib in Renal Cell Carcinoma and Soft Tissue Sarcoma: A Systematic Review.
    Turjap M; Pelcová M; Gregorová J; Šmak P; Martin H; Štingl J; Peš O; Juřica J
    Ther Drug Monit; 2024 Jun; 46(3):321-331. PubMed ID: 38723115
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comparing Sonazoid contrast-enhanced ultrasound to contrast-enhanced CT and MRI for differentially diagnosing renal lesions: a prospective multicenter study.
    Zhao QX; Wu C; Tan S; Yang Y; Cui XW; Dietrich CF; Yang B; Xu CL; Gao YY; Xie MX; Wu CJ; Liu LP; Wang XH; Ling-Hu RZ; Wang N; Wang F; Wang XL; Liu GY; Yu XL; Yu J; Cheng ZG; Liang P
    World J Urol; 2024 May; 42(1):302. PubMed ID: 38720010
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Risk of Subsequent Primary Cancers Among Adult-Onset 5-Year Cancer Survivors in South Korea: Retrospective Cohort Study.
    Choi YY; Lee M; Kim EH; Lee JE; Jung I; Cheong JH
    JMIR Public Health Surveill; 2024 May; 10():e48380. PubMed ID: 38717807
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinical and pathological characteristics of renal cell carcinomas with MiTF translocation.
    Filler T; Verkarre V; Peyrottes A; Poinard F; Lupo A; Dariane C; Hurel S; Timsit MO; Mejean A; Audenet F
    Fr J Urol; 2024 Mar; 34(2):102569. PubMed ID: 38717457
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Robot-assisted partial nephrectomy in patients aged 75 years or older - comparing the risk of complications with their younger counterparts.
    Petersson RD; Fode M; Niebuhr MH; Rashu BS; Thomsen FF
    Aging Clin Exp Res; 2024 May; 36(1):107. PubMed ID: 38714631
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Decomposing difference in the kidney cancer burden measures between 1990 and 2019 based on the global burden of disease study.
    Ayubi E; Shahbazi F; Khazaei S
    Sci Rep; 2024 May; 14(1):10390. PubMed ID: 38710935
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Evolving horizons in renal angiomyolipoma: two decades of management strategies and clinical perspectives in a single institutional study.
    Keles A; Iplikci A; Arikan O; Culpan M; Baydili KN; Keser F; Yildirim A
    Aging Male; 2024 Dec; 27(1):2346308. PubMed ID: 38709235
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Identification of key genes in Wilms tumor based on high-throughput RNA sequencing and their impacts on prognosis and immune responses].
    Gao Z; Lin J; Hong P; Hu Z; Dong J; Shi Q; Tian X; Liu F; Wei G
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):727-738. PubMed ID: 38708507
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1169.